Cargando…
Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy
BACKGROUND: Factors excluding postoperative pancreatic fistula (POPF), facilitating early drain removal and hospital discharge represent a novel approach in patients undergoing enhanced recovery after pancreatic surgery. This study aimed to establish the relevance of neutrophil-to-lymphocyte ratio (...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835509/ https://www.ncbi.nlm.nih.gov/pubmed/36633417 http://dx.doi.org/10.1093/bjsopen/zrac124 |
_version_ | 1784868681825648640 |
---|---|
author | Garnier, Jonathan Alfano, Marie-Sophie Robin, Fabien Ewald, Jacques Al Farai, Abdallah Palen, Anais Sebai, Amine Mokart, Djamel Delpero, Jean-Robert Sulpice, Laurent Zemmour, Christophe Turrini, Olivier |
author_facet | Garnier, Jonathan Alfano, Marie-Sophie Robin, Fabien Ewald, Jacques Al Farai, Abdallah Palen, Anais Sebai, Amine Mokart, Djamel Delpero, Jean-Robert Sulpice, Laurent Zemmour, Christophe Turrini, Olivier |
author_sort | Garnier, Jonathan |
collection | PubMed |
description | BACKGROUND: Factors excluding postoperative pancreatic fistula (POPF), facilitating early drain removal and hospital discharge represent a novel approach in patients undergoing enhanced recovery after pancreatic surgery. This study aimed to establish the relevance of neutrophil-to-lymphocyte ratio (NLR) in excluding POPF after pancreatoduodenectomy (PD). METHODS: A prospectively maintained database of patients who underwent PD at two high-volume centres was used. Patients were divided into three cohorts (training, internal, and external validation). The primary endpoints of this study were accuracy, optimal timing, and cutoff values of NLR for excluding POPF after PD. RESULTS: From 2012 to 2020, in a 2:1 ratio, 451 consecutive patients were randomly sampled as training (n = 301) and validation (n = 150) cohorts. Additionally, the external validation cohort included 197 patients between 2018 and 2020. POPF was diagnosed in 135 (20.8 per cent) patients. The 90-day mortality rate was 4.1 per cent. NLR less than 8.5 on postoperative day 3 (OR, 95 per cent c.i.) was significantly associated with the absence of POPF in the training (2.41, 1.19 to 4.88; P = 0.015), internal validation (5.59, 2.02 to 15.43; P = 0.001), and external validation (5.13, 1.67 to 15.76; P = 0.004) cohorts when adjusted for relevant clinical factors. Postoperative outcomes significantly differed using this threshold. CONCLUSION: NLR less than 8.5 on postoperative day 3 may be a simple, independent, cost-effective, and easy-to-use criterion for excluding POPF. |
format | Online Article Text |
id | pubmed-9835509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98355092023-01-17 Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy Garnier, Jonathan Alfano, Marie-Sophie Robin, Fabien Ewald, Jacques Al Farai, Abdallah Palen, Anais Sebai, Amine Mokart, Djamel Delpero, Jean-Robert Sulpice, Laurent Zemmour, Christophe Turrini, Olivier BJS Open Original Article BACKGROUND: Factors excluding postoperative pancreatic fistula (POPF), facilitating early drain removal and hospital discharge represent a novel approach in patients undergoing enhanced recovery after pancreatic surgery. This study aimed to establish the relevance of neutrophil-to-lymphocyte ratio (NLR) in excluding POPF after pancreatoduodenectomy (PD). METHODS: A prospectively maintained database of patients who underwent PD at two high-volume centres was used. Patients were divided into three cohorts (training, internal, and external validation). The primary endpoints of this study were accuracy, optimal timing, and cutoff values of NLR for excluding POPF after PD. RESULTS: From 2012 to 2020, in a 2:1 ratio, 451 consecutive patients were randomly sampled as training (n = 301) and validation (n = 150) cohorts. Additionally, the external validation cohort included 197 patients between 2018 and 2020. POPF was diagnosed in 135 (20.8 per cent) patients. The 90-day mortality rate was 4.1 per cent. NLR less than 8.5 on postoperative day 3 (OR, 95 per cent c.i.) was significantly associated with the absence of POPF in the training (2.41, 1.19 to 4.88; P = 0.015), internal validation (5.59, 2.02 to 15.43; P = 0.001), and external validation (5.13, 1.67 to 15.76; P = 0.004) cohorts when adjusted for relevant clinical factors. Postoperative outcomes significantly differed using this threshold. CONCLUSION: NLR less than 8.5 on postoperative day 3 may be a simple, independent, cost-effective, and easy-to-use criterion for excluding POPF. Oxford University Press 2023-01-12 /pmc/articles/PMC9835509/ /pubmed/36633417 http://dx.doi.org/10.1093/bjsopen/zrac124 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Garnier, Jonathan Alfano, Marie-Sophie Robin, Fabien Ewald, Jacques Al Farai, Abdallah Palen, Anais Sebai, Amine Mokart, Djamel Delpero, Jean-Robert Sulpice, Laurent Zemmour, Christophe Turrini, Olivier Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
title | Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
title_full | Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
title_fullStr | Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
title_full_unstemmed | Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
title_short | Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
title_sort | establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835509/ https://www.ncbi.nlm.nih.gov/pubmed/36633417 http://dx.doi.org/10.1093/bjsopen/zrac124 |
work_keys_str_mv | AT garnierjonathan establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT alfanomariesophie establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT robinfabien establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT ewaldjacques establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT alfaraiabdallah establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT palenanais establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT sebaiamine establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT mokartdjamel establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT delperojeanrobert establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT sulpicelaurent establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT zemmourchristophe establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy AT turriniolivier establishmentandexternalvalidationofneutrophiltolymphocyteratioinexcludingpostoperativepancreaticfistulaafterpancreatoduodenectomy |